Multimodal bioimaging development has gathered significant pace in recent years, was recently highlighted as a ‘method to watch’ 1, and is poised to transform the way in which researchers approach ...

Advances in quantitative biomarker development have accelerated new forms of data-driven insights for patients with cancer. However, most approaches are limited to a single mode of data, leaving ...